These findings, together with the association of circulating monocyte count with TLR2 and TLR-4 VAT mRNA expression levels and eosinophil count with IL-1β, IL-6, IL-10, and IL-1RA VAT expression levels in women with GDM, suggest that systemic inflammation is accompanied by dysregulated VAT expression of inflammatory genes in women with GDM. This evidence concerns the gene IL1B and gestational diabetes.